Muromonab cd3

Definition
This section has been translated automatically.

Immunosuppressant.

Pharmacodynamics (Effect)
This section has been translated automatically.

Monoclonal antibody against the T3 antigen of human T cells.

You might also be interested in

Advertisment

Dermatology

Nodular or nodular basal cell carcinoma. Relatively inconspicuous, non-symptomatic, red nodule wi...

Basal cell carcinoma nodular

Most common basal cell carcinoma (about 60% of the basal cell carcinomas that occur), characterised by nodu...

Indication
This section has been translated automatically.

Prophylaxis of rejection reactions after heart, liver or kidney transplantation; for the treatment of autoimmune diseases currently in clinical trials.

Dosage and method of use
This section has been translated automatically.

5 mg/day i.v., 1-4 hours before first administration 8 mg/kg bw methylprednisolone i.v. (to avoid allergic reactions).

Undesirable effects
This section has been translated automatically.

See Table 1.

Interactions
This section has been translated automatically.

See Table 2.

Contraindication
This section has been translated automatically.

Pregnancy, lactation, hypersensitivity to mouse products (anti-mouse antibodies > 1:1000), water retention, heart failure, seizures in the medical history.

Preparations
This section has been translated automatically.

Orthoclone OKT 3

Tables
This section has been translated automatically.

Major side effects of Muromonab CD3

Airways	Dyspnoea, bronchospasm, flu-like symptoms Respiratory arrest Hyperventilation Pulmonary oedema, pneumonia, pneumonitis
Blood, lymph	aplastic anemia Blood coagulation disorders Eosinophilia leukocytosis, leukopenia, pancytopenia Splenomegaly, lymphadenopathy, lymphomas
GIT	Abdominal pain, gastrointestinal disturbances Transaminase increase hepatitis, hepatomegaly
Urinary tract	Anuria, Oliguria Glomerulonephritis Urea and creatinine increase
Skin	herpes simplex Pruritus, erythema, exanthema, urticaria, Quincke's edema, anaphylactic reactions spinocellular carcinomas
Cardiovascular	Hypertension, tachycardia Angina pectoris, cardiac arrhythmia, myocardial infarction temporal arteritis Thrombosis Subarachnoid hemorrhage
Nervous System	Headaches Rigor, Tremor loss of consciousness, delirium, hallucinations encephalopathy, brain edema Seizures aseptic meningitis Tetraplegia
Sensory Organs	double images, blurred vision, reduced vision to blindness conjunctivitis, photophobia Rotational vertigo hearing loss, tinnitus, otitis media
Support apparatus	Arthralgia, Myalgia Muscle twitching
System reactions	30-60 min. after administration: fever, chills

Significant interactions of Muromonab CD3

Azathioprine	Encephalopathy, infections, carcinogenicity ↑
Ciclosporin A	Encephalopathy, infections, carcinogenicity ↑
Glucocorticoids	Encephalopathy, infections, carcinogenicity ↑
Indomethacin	Encephalopathy